BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 121 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $48,000 | +140.0% | 10,000 | 0.0% | 0.01% | +66.7% |
| Q1 2020 | $20,000 | -42.9% | 10,000 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $35,000 | +20.7% | 10,000 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $29,000 | -23.7% | 10,000 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $38,000 | -53.1% | 10,000 | 0.0% | 0.00% | -55.6% |
| Q1 2019 | $81,000 | 0.0% | 10,000 | 0.0% | 0.01% | -18.2% |
| Q4 2018 | $81,000 | -1.2% | 10,000 | -7.4% | 0.01% | +22.2% |
| Q3 2018 | $82,000 | +32.3% | 10,800 | 0.0% | 0.01% | +28.6% |
| Q2 2018 | $62,000 | +19.2% | 10,800 | 0.0% | 0.01% | +16.7% |
| Q1 2018 | $52,000 | -8.8% | 10,800 | -7.3% | 0.01% | -14.3% |
| Q4 2017 | $57,000 | -8.1% | 11,650 | -2.9% | 0.01% | -12.5% |
| Q3 2017 | $62,000 | -7.5% | 12,000 | 0.0% | 0.01% | -11.1% |
| Q2 2017 | $67,000 | -33.7% | 12,000 | 0.0% | 0.01% | -35.7% |
| Q1 2017 | $101,000 | -15.8% | 12,000 | -36.8% | 0.01% | -22.2% |
| Q4 2016 | $120,000 | +42.9% | 19,000 | 0.0% | 0.02% | +38.5% |
| Q3 2016 | $84,000 | +55.6% | 19,000 | 0.0% | 0.01% | +44.4% |
| Q2 2016 | $54,000 | +1.9% | 19,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $53,000 | -73.0% | 19,000 | 0.0% | 0.01% | -74.3% |
| Q4 2015 | $196,000 | -9.7% | 19,000 | 0.0% | 0.04% | -14.6% |
| Q3 2015 | $217,000 | -23.3% | 19,000 | 0.0% | 0.04% | -16.3% |
| Q2 2015 | $283,000 | – | 19,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |